NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/06/2026
Back to search
Official data from USPTO
LCB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
01/06/2026
Trademark type
Combined
Nice classes
42
Filing date
12/24/2024
Registration date
01/06/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/06/2026
Last transaction
01/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
5
Owner type
03
Owner location
Yuseong-gu, Daejeon, KR
Examiner
OJEYEMI,ASHLEY CHRISTINE
Law office
O10
Current location
INTENT TO USE SECTION
Mark description
The mark consists of the stylized letters "LCB" in the color brown.
Holders and representatives
Holders
LigaChem Biosciences Inc.
Representatives
Richard Y. Kim Snell & Wilmer L.L.P.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of vaccines and medicines; biomedical research services; biological research and analysis; research of crude drugs; biochemical research and analysis; bacteriological research and analysis; drug discovery services; Research and development in the field of pharmaceuticals and biotechnology; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research in the field of pharmaceuticals; research on the subject of pharmaceuticals; drug developmentpharmaceutical drug development services in the fields of canceroncological disordersautoimmune diseasesinflammatory diseasesfibrotic diseases and infectious diseases; pharmaceutical research and development; pharmaceutical drug development services; consultancy pertaining to pharmacology; medical and pharmaceutical research services; research in the field of medical preparations; medical research laboratory services; medicine researchmedical research services relating to medicines in the fields of canceroncological disordersautoimmune diseasesinflammatory diseasesfibrotic diseases and infectious diseases; providing PAAS (platform as a service) featuring computer software used to conduct research and development in the field of pharmaceuticalsbiotechnology and drugs; laboratory research services relating to pharmaceuticals; Technology research in the field of medical instruments; testing of pharmaceuticals; medical and scientific researchconducting clinical trials for others; chemical research and analysis
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/06/2026
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
12/18/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
12/18/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/16/2025
CHPB
POST PUBLICATION AMENDMENT - ENTERED
12/05/2025
APET
ASSIGNED TO PETITION STAFF
12/05/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/21/2025
PUBO
PUBLISHED FOR OPPOSITION
10/21/2025
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
10/20/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/15/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/18/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/16/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/09/2025
GNRT
NON-FINAL ACTION E-MAILED
07/09/2025
CNRT
NON-FINAL ACTION WRITTEN
07/09/2025
DOCK
ASSIGNED TO EXAMINER
06/10/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/03/2025
NWAP
NEW APPLICATION ENTERED
12/24/2024
Continuous trademark protection
Get notified about every new filing that threatens LCB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.